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Abstract
Background
Trypanosoma cruzi, causative agent of Chagas disease in humans and dogs, is a vector-
borne zoonotic protozoan parasite that can cause fatal cardiac disease. While recognized
as the most economically important parasitic infection in Latin America, the incidence of
Chagas disease in the United States of America (US) may be underreported and even
increasing. The extensive genetic diversity of T. cruzi in Latin America is well-documented
and likely influences disease progression, severity and treatment efficacy; however, little is
known regarding T. cruzi strains endemic to the US. It is therefore important to expand our
knowledge on US T. cruzi strains, to improve upon the recognition of and response to locally
acquired infections.
Methodology/Principle Findings
We conducted a study of T. cruzimolecular diversity in California, augmenting sparse
genetic data from southern California and for the first time investigating genetic sequences
from northern California. The vector Triatoma protracta was collected from southern
(Escondido and Los Angeles) and northern (Vallecito) California regions. Samples were ini-
tially screened via sensitive nuclear repetitive DNA and kinetoplast minicircle DNA PCR
assays, yielding an overall prevalence of approximately 28% and 55% for southern and
northern California regions, respectively. Positive samples were further processed to iden-
tify discrete typing units (DTUs), revealing both TcI and TcIV lineages in southern California,
but only TcI in northern California. Phylogenetic analyses (targeting COII-ND1, TR and
RB19 genes) were performed on a subset of positive samples to compare Californian T.
cruzi samples to strains from other US regions and Latin America. Results indicated that
within the TcI DTU, California sequences were similar to those from the southeastern US,
as well as to several isolates from Latin America responsible for causing Chagas disease in
humans.
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Conclusions/Significance
Triatoma protracta populations in California are frequently infected with T. cruzi. Our data
extend the northern limits of the range of TcI and identify a novel genetic exchange event
between TcI and TcIV. High similarity between sequences from California and specific Latin
American strains indicates US strains may be equally capable of causing human disease.
Additional genetic characterization of Californian and other US T. cruzi strains is
recommended.
Author Summary
Trypanosoma cruzi is a protozoan parasite that causes Chagas disease in humans and dogs
and may eventually lead to mortalities related to cardiac failure. This parasite is most fre-
quently transmitted by triatomine bug vectors, commonly called “kissing bugs.” Although
Chagas disease is predominately acquired in Latin American countries, T. cruzi exists in
wildlife and vectors in some parts of the United States of America (US), including regions
of California. Within the US, occasional cases of locally acquired Chagas disease have been
reported, and recent serological surveys indicate that T. cruzi exposure may be occurring
more commonly than previously realized. However, relatively little molecular research has
been performed on the T. cruzi strains present in the US, especially within California. In
this study, we collected nearly 100 kissing bugs from regions of northern and southern
California to determine the T. cruzi prevalence and genetic diversity for each region’s kiss-
ing bug population. We compared DNA sequences obtained in this study to those of sev-
eral T. cruzi strains found in Latin America and the southeastern US. Based on our data,
we conclude that Californian T. cruzi samples are closely related to strains found in Latin
America known to be associated with human infections.
Introduction
Trypanosoma cruzi is a protozoan parasite that, in both humans and dogs, may cause an insidi-
ous onset of fatal cardiac disease[1]. Known as Chagas disease, T. cruzi is the most economi-
cally important parasitic infection in Latin America, where an estimated 8–9 million people are
living with the chronic disease [2]. The parasite is most commonly transmitted vectorially, by
numerous species of triatomine bugs (commonly called “kissing bugs”), distributed from Chile
and Argentina in South America to approximately 42.5 degrees northern latitude of the United
States of America [3, 4]. Only seven authochthonous clinical cases of Chagas disease in humans
have been officially documented in the United States despite the fact that nine endemic Tria-
toma species are known to harbor T. cruzi [1]. The prevalence of infection varies among Tria-
toma species and across geographic regions [5, 6] and has been reported to be as high as 61%
in Louisiana [7].
In the US, T. cruzi has been found in wild canids; numerous rodent species; and mesomam-
mals such as raccoons, opossums and skunks [1]. The prevalence of T. cruzi in various wildlife
species has ranged upwards from 50% in Texas and some southeastern states [8, 9]. Many of
these mammals are peri-urban species that adapt well to human-modified landscapes and, if
infected, can bring T. cruzi closer to humans and their canine companions. In turn, when tria-
tomines are present in the local environment, there may be a subsequent increased risk of
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vectorial T. cruzi transmission to people, and an even greater transmission risk to dogs, who
likely acquire T. cruzi via ingestion of infected vectors [10, 11]. In 2006, the Texas Veterinary
Medical Diagnostic Laboratory reported 18.6% of 532 dogs presumably clinically ill with car-
diac disease to be seropositive for T. cruzi [12]. In addition, canine serological surveys in states
such as Tennessee, Louisiana and Texas indicate that T. cruzi infection is not an uncommon
occurrence, even in apparently healthy domestic dogs [13–15]. Likewise, recent human sero-
logical surveys and Triatoma blood meal analyses suggest that human T. cruzi exposure may
also occur more frequently than previously realized [16–18]. Physicians and veterinarians are
not well-trained to recognize this disease in the US; treatment is not readily available [19]; and
there are no drugs approved for veterinary use [1]. Understanding of the ecology of T. cruzi in
the US, including vector and reservoir distribution, and of the molecular epidemiology of
endemic strains will enable health and disease control professionals to better respond to the
likely rising incidence of Chagas disease.
Trypanosoma cruzi taxonomy has been revised, with the most recent consensus classifying
the organism into six subtypes or ‘discrete typing units’ (DTUs), designated TcI to TcVI [20].
Within each DTU fall numerous strains whose unique identities are generally determined via
typing of several independent genetic loci. Very little T. cruzimolecular epidemiology research
has been done in the US as compared to that accomplished in Latin American countries [21],
despite the concern that Chagas may become an emerging disease in the country [19, 22, 23].
Most research on US T. cruzi has been restricted to typing to the DTU level, and to date, only
TcI and TcIV have been detected in local vectors and wildlife [9, 24]. Researchers have recently
begun to explore intra-DTU molecular diversity, focusing on isolates from the southeastern US
[21]. However, data on genetic diversity in southwestern regions (e.g. California, Arizona, and
NewMexico) are very limited [25].
California has the largest influx of migrants of any state in the US [26], with 53% of the
immigrant population of Latin American origin [27]. Additionally, 2011 US census data indi-
cates that more than 21% of the nearly 3 million South American migrants residing in the US
live in California, with estimates of 75,000–399,000 living in Los Angeles alone [28]. It is there-
fore probable that many exogenous strains of T. cruzi enter California every year via human
migration. It has been experimentally demonstrated that at least one virulent Honduran strain
can be viable if introduced into Tr. protracta, the most common triatomine bug vector in Cali-
fornia [29]. Thus, the pool of T. cruzi strains present in the US may potentially become more
diverse. Additionally, with global climate change, it has been predicted that the human popula-
tion at risk for T. cruzi transmission will increase in southern California due to increased triato-
mine activity associated with warmer temperatures [23]. Therefore, in addition to monitoring
T. cruzi vector distribution, it is important to investigate the molecular genetics of endemic
strains; how they compare to virulent strains in Latin America; and whether recently intro-
duced strains may already exist in local vectors. To this end, the goals of this study were to: 1)
compare the prevalence and DTUs of T. cruzi within triatomine bug populations from two
regions of California and 2) further characterize the California T. cruzi samples via molecular
genetics to assess whether there are regional differences and to determine how the California
samples compare to those present in other regions of the US and Latin America.
Methods
Sample collection
Triatoma protracta specimens were actively collected from private residences in two study
regions. All landowners consented to the collection of bugs from their properties. The first
study area was located in southern California, in the town of Escondido (33.1247° N, 117.0808°
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W). This study site was chosen because previous research had identified T. cruzi in the resident
triatomine bug population [25]. Abundant woodrat (Neotoma macrotis) nests were found, and
much of the terrain was covered with large granite-based boulders and smaller rocks that pro-
vided crevices for triatomines. The second study area encompassed several residences in the
town of Vallecito, situated in northern California (38.0903° N, 120.4736° W). This location was
selected based on knowledge that multiple triatomine bugs collected there in 2011 were positive
for T. cruzi (M. Niemela, pers comm). Woodrat nests at these properties varied by site but were
generally less abundant than the Escondido location.
Black light traps were used in July and August 2012 to collect adult bugs from both study
regions. Lights were turned on approximately 30 minutes before sunset and left on for at least
two hours after sunset to coincide with the evening hours during which the adult bugs were fly-
ing (C. Conlan, pers comm) [30]. The bugs often did not fly the complete distance to the light
trap; therefore, combing the surrounding area facilitated capture of bugs crawling on the
ground nearby. This trapping method worked well in Escondido, where the trap was strategi-
cally placed at the top of a hill and the vegetation on the slope below consisted of small shrubs
that did not obscure the emanating light. Light trapping was less successful in Vallecito. Hence,
to augment the triatomine sample size from this region, we enlisted the help of property own-
ers to collect bugs found in their homes. We also partially excavated several woodrat nests to
obtain both adult and nymphal bugs. All bugs were placed in tubes and frozen at -20C° until
laboratory processing.
In addition, we opportunistically obtained specimens from public health employees in
southern California, who often received bugs from concerned citizens, especially if the bug had
bitten someone within the home. These bugs were shipped to the laboratory either frozen or in
ethyl alcohol during the months of April-July 2012 and June-August 2013.
Laboratory procedures
DNA extraction. DNA extractions were performed following the tissue protocol of the
QIAamp DNA Blood and Tissue extraction kit (Qiagen). A new razor blade was used to excise
the terminal abdominal segments of the Tr. protracta specimens onto a fresh microscope slide,
to which 20 μl of PBS was added before finely chopping the insect tissues. The resulting
homogenate was transferred to a 1.5 ml microcentrifuge tube, and the remaining DNA extrac-
tion process followed the kit protocol. The final DNA was eluted in 100 μl of AE buffer.
Following the extraction of DNA, polymerase chain reaction (PCR) assays were used to, 1)
screen each sample for the presence or absence of T. cruzi DNA, 2) identify the DTU of each
positive sample (i.e. TcI to TcVI), and 3) obtain additional partial gene sequences for phyloge-
netic analyses. Table 1 lists the primers, reaction and thermocycling conditions (as performed
in our lab) and expected amplicon size for all PCR assays. All PCR products were visualized via
gel electrophoresis using 1.5% agarose, with the exception of the TcZ nuclear and large subunit
ribosomal DNA (LSU rDNA) assays, which were run on 2% and 2.5% gels, respectively. DNA
extraction, PCR amplification and cloning procedures were performed in dedicated laboratory
spaces to avoid the potential for contamination. Each PCR assay contained a negative water
and one or more T. cruzi positive controls (Y-strain and a sequence-confirmed positive CA
sample) as quality control measures.
T. cruzi screening assays. Samples were first screened for the presence of T. cruzi using
the primers TcZ1/TcZ2 [31] and 121/122 [32], which target very high copy number target loci
(>104 per parasite). If the results of these assays were discordant, then the assay giving negative
results was repeated in triplicate. If at least one of these replicates resulted in a positive band,
then the sample was considered positive for that assay. Samples that yielded amplicons of the
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expected sizes for both sets of screening primers were not confirmed via sequencing. If the tar-
get band was only visible for one of the two assays, the DNA from this band was extracted,
cloned and sequenced to confirm whether the sample was positive.
Discrete typing unit assays. The DTU analysis was performed following a modified ver-
sion of the triple-assay protocol proposed by Lewis et al [37]. As illustrated in Fig 1, the pri-
mary PCR assay targets the large subunit ribosomal DNA (LSU rDNA) to amplify the D7
divergent domain of the 24S-α rRNA locus using the primers D71/D72 [33]. Based on previous
studies, the assay was expected to yield DNA sequences of the following sizes: 110 bp (TcI,
TCIII, or TCV); 125 bp (TcII, TcIV, or TcVI); 110 bp + 125 bp (TcV); and 117 bp, 120 bp or
130 bp (TcIV). DNA sequencing analysis was performed on multiple target 110 bp and 125 bp
bands to gain representation across both study regions.
The second DTU assay amplified a 432–462 bp segment of the heat-shock protein 60
(HSP60). Restriction fragment length polymorphism (RFLP) of this amplicon with EcoRV
results in 1–3 bands (Fig 1). TcI, TcIII and TcV, all of which demonstrate a 110 bp band with
Table 1. Trypanosoma cruzi PCR assays used for screening, discrete typing unit (DTU), and phylogenetic analyses.
PCR assay1 Forward/Reverse Primers & (Reaction conditions) bp2 Cycling conditions (‘ =
minutes;” = seconds)
Cloning3
S: TcZ nuclear
195bp satellite [31]
TcZ1: 5'-CGA GCT CTT GCC CAC ACG GGT GCT-3' / TcZ2: 5'-CCT
CCA AGC AGC GGA TAG TTC AGG-3' (20μl: 1.9mM MgCl2, 0.2mM
each dNTPs, 0.5μM each primer, 0.25U Taq & 4μl buffer)
188 94° x 5’ (94° x 20”, 57° x
10”, 72° x 30”)35; 72° x 7’
1
S: kDNA minicircle
[32]
121: 5'-AAA TAA TGT ACG GGK GAG ATG CAT GA-3' / 122: 5'-GGT
TCG ATT GGG GTT GGT GTA ATA TA-3' (25μl: 1.5mM MgCl2, 0.2mM
each dNTPs, 0.4μM each primer, 0.625U Taq & 5μl buffer)
330 95° x 10’ (94° x 30”, 58° x
30”, 72° x 1’)35; 72° x 10’
1
DTU: LSU rDNA
[33]
D71: 5'-AAG GTG CGT CGA CAG TGT GG-3' / D72: 5'-TTT TCA GAA
TGG CCG AAC AGT-3' (25μl: 1.5mM MgCl2, 0.1mM each dNTPs,
0.4μM each primer, 1U Taq & 5μl buffer)
varies 94° x 3’ (94° x 1’, 60° x 1’,
72° x 1’)35; 72° x 10’
1
DTU: HSP60 [34] For: 5'-GTG GTA TGG G TGA CAT GTA C-3' / Rev: 5'-CGA GCA GCA
G AGC GAA ACA T-3' (50μl: 2mM MgCl2, 0.1mM each dNTPs, 0.4μM
each primer, 2U Taq & 13.3μl buffer)
432–462
prior to
RFLP4
94° x 3’ (94° x 30”, 52° x
30”, 72° x 1’)35; 72° x 10’
1
DTU: Mini-exon [33]
5
TC: 5’-CCC CCC TCC CAG GCC ACA CTG-3’ / TC1: 5’- GTG TCC
GCC ACC TCC TTC GGG CC-3’ / TC2: 5’-CCT GCA GGC ACA CGT
GTG TGT G-3’ (25μl: 1.5 MgCl2, 0.2mM each dNTPs, 1μM each
primer, 1U Taq & 5μl buffer)
varies 94° x 3’ (94° x 30”, 60° x
30”, 72° x 30”)27; 72° x 10’
1
DTU: GPI [34] For: 5'-GGC ATG TGA AGC TTT GAG GCC TTT TTC AG-3' / Rev: 5'-
TGT AAG GGC CCA GTG AGA GCG TTC GTT GAA TAG C-3' (50μl:
2mM MgCl2, 0.1mM each dNTPs, 0.4μM each primer, 2U Taq & 13.3μl
buffer)
1264 prior to
RFLP4
94° x 3’ (94° x 30”, 52° x
30”, 72° x 1’)35; 72° x 10’
1
P: COII-ND1
maxicircle [35]
ND3.1A: 5’-GCT ACT ART TCA CTT TCA CAT TC-3’ / COII.2A: 5’-
GCA TAA ATC CAT GTA AGA CMC CAC A-3’ (25μl: 1.5 MgCl2,
0.2mM each dNTPs, 1μM each primer, 1U Taq & 5μl buffer)
1272 94° x 5’ (94° x 30”, 50° x
30”, 72° x 30”)30; 72° x 7’
2
P: TR nuclear [35] TR Y2S: 5’-ACT GGA GGC TGC TTG GAA CGC-3’ / TR Y2A: 5’-GGA
TGC ACA CCR ATR GTG TTG T-3’ (25μl: 1.5 MgCl2, 0.2mM each
dNTPs, 0.5μM each primer, 1U Taq & 5μl buffer)
1335 94° x 5’ (94° x 1’, 55° x 1’,
72° x 1’)30; 72° x 5’
1
P: RB19 nuclear
[36]
RB19F: 5’-GCC TAC ACC GAG GAG TAC CA-3’ / RB19R: 5’-TTC
TCC AAT CCC CAG ACT TG-3’ (25μl: 1.5 MgCl2, 0.2mM each dNTPs,
0.5μM each primer, 1U Taq & 5μl buffer)
408 94° x 5’ (94° x 1’, 55° x 1’,
72° x 1’)30; 72° x 5’
3
1Bracketed numbers correspond to the original references for each assay. S = Screening; P = Phylogenetic
2The target base pair amplicon sizes; for some assays the size varies by the discrete typing unit as depicted in Fig 1
3Cloning methods were M13 PCR amplification followed by ExoSapIT (1), Qiagen MiniPrep method followed by EcoRI digestion (2), or direct sequencing
without cloning (3).
4See Fig 1 for details on the restriction fragment length polymorphism (RFLP) banding pattern for HSP60 and GPI.
5Multiplex PCR assay with three primers.
doi:10.1371/journal.pntd.0004291.t001
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the LSU rDNA assay, are differentiated in the HSP60 analysis by yielding 1, 2 or 3 RFLP bands,
respectively. Likewise, TcII, TcIV and TcVI may all result in a 125 bp band with the primary
assay; however, upon RFLP of theHSP60 sequence, three bands are visualized for TcVI, sepa-
rating this DTU from TcII and TcIV, both of which only produce a single band.
The non-transcribed intergenic region of the SL-RNA (mini-exon) array [33] was used as
the third step in the DTU analysis. The mini-exon assay differentiates TcII from TcIV, with
300 bp and 400 bp bands (or no band) amplified, respectively [37]. In this study, the glucose
phosphate isomerase (GPI) RFLP assay was only occasionally used as a confirmatory test,
because it does not differentiate between TcI and the North American TcIV genotype (Fig 1).
Phylogenetic marker PCR assays. We selected two single-copy nuclear genes for our phy-
logenetic analyses, trypanothione reductase (TR) and RNA binding-protein-19 (RB19). These
genes had previously demonstrated strong discriminatory power among both TcI and TcIV
isolates [36]. Few published sequences from US T. cruzi isolates were available for the TR and
RB19 genes, and there were no TR sequences from TcIV US isolates. However, we expected
Fig 1. PCR assay flowsheet1 to identify Trypanosoma cruzi discrete typing units (DTUs).Directional arrows indicate assay order and stop signs denote
when sufficient data was gathered to theoretically identify the DTU. The final assay (GPI) is included as a confirmatory step, but is not required for DTU
identification. 1Modified from Lewis et al. [37] 2The large subunit rDNA assay is also referred to as the 24sα rRNA gene assay. 3An additional band of
approximately 125bp may or may not be visible in combination with the 110bp band. 4Heat Shock Protein-60 (HSP60) results in an amplicon of 432-462bp,
which upon RFLP with EcoV restriction enzyme yields the following patterns: 1 band (432–462), 2 bands (118–148 + 314), or 3 bands (118–148 + 314
+ 432–462). 5This PCR used a pool of three primers to amplify a portion of the non-transcribed intergenic region of the tandemly repeated mini-exon gene.
6Glucose Phosphate Isomerase (GPI) results in an amplicon of approximately 1264bp, which upon RFLP with HhaI restriction enzyme yields the following
patterns: 2 bands (447 + 817), 3 bands (253 + 447 + 490), or 4 bands (253 + 447 + 490 + 817). TcIV will display 2 or 3 bands for North American and South
American strains, respectively.
doi:10.1371/journal.pntd.0004291.g001
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that the use of TR and RB19 would be more valuable than the inclusion of other nuclear genes
previously examined by Roellig et al. [21], which showed low resolution for US isolates. Fur-
thermore, a large number of TR and RB19 reference sequences are available for comparison
with isolates from other endemic countries [35, 38–40]. To increase the sensitivity of these
PCR assays, bovine serum albumin was added to the PCR buffer at 0.96 mg/ml [41].
We used the primers ND1.3A and COII.2A to amplify a segment of the kinetoplast maxicir-
cle contiguous genes, NADH dehydrogenase subunit 1 (ND1) and cytochrome oxidase subunit
2 (COII). A major advantage of this gene selection was the availability of homologous
sequences for both TcI and TcIV from a broad geographic range, including a large number of
isolates from the United States [21]. Secondly, T. cruzimitochondrial maxicircle genes undergo
a faster mutation rate than do nuclear genes [42]. Therefore these sequences were expected to
provide better differentiation both among our isolates and with respect to Latin American
strains. Finally, individual parasites contain up to 50 maxicircle copies [42], thus potentially
increasing the sensitivity of the PCR as compared to single-copy nuclear genes.
Cloning and sequencing methods. The Qiaquick Gel Extraction kit (Qiagen) was used to
purify amplicons for either direct sequencing (RB19) or cloning (all other assays). Purified
products were cloned following the processes described in the TOPO TA cloning kit for
sequencing with One Shot TOP10 chemically competent E. coli cells (Invitrogen).
With the exception of the COII-ND1 assay, amplification of inserted plasmid DNA was via
the colony-PCR method [43]. Selected colonies were transferred directly into individual 200 μl
PCR tubes containing the M13 PCR mastermix. Each 1X reaction contained the following:
18.15 μl of PCR grade water, 2.5 μl PCR buffer (10x), 1.5 mMMgCl2, 200 μM each dNTP, 0.5
Units of GoTaq DNA polymerase (Promega 5U/μl) and 0.4 μM each of M13 forward (5’–GTA
AAA CGA CGG CCA G– 3’) and M13 reverse (5’–CAG GAA ACA GCT ATG AC– 3’) prim-
ers. The thermocycling conditions were 94°C (5 minutes); 35 cycles of 94°C (30 seconds), 46°C
(30 seconds), 72°C (60 seconds); followed by a final extension at 72°C (5 minutes). PCR prod-
ucts were purified following the USB ExoSAP-IT protocol (USB Products).
COII-ND1 amplicons were cloned using a modified procedure. First, during the TOPO
cloning reaction process, we diluted the vector solution to a total volume of 20 μl, a recom-
mended technique for cloning large inserts [44]. Transformation of cells and plating were per-
formed as above. Several colonies from each plate were selected for additional overnight
incubation (37°C) in separate tubes containing 4 ml LB agar broth plus 4 μl of ampicillin
(100mg/ml). The tubes were then centrifuged for 5 minutes at 1500 rpm, and plasmid DNA
was purified from the pellet using the QIAprep Spin Miniprep kit (Qiagen). EcoRI digestion
followed by gel electrophoresis confirmed successful cloning attempts.
All sequencing was performed at the UC Davis Sequencing Lab using ABI Prism analyzer
and software. Bidirectional sequences were assembled in Geneious version 5.3.6 (http://www.
geneious.com [45]). To confirm that the sequences were derived from T. cruzi, a comparative
search of electronically archived T. cruzi sequences was run via BLAST in GenBank (http://
www.ncbi.nlm.nih.gov/genbank/). The COII-ND1, RB19 and TR sequences obtained in this
study were submitted to GenBank under the accession numbers KR108801-KR108827 and
KR135412-KR135425.
Phylogenetic Analyses
The program Geneious was used for the assembly and alignment of maxicircle and nuclear
sequences. Previously published COII-ND1, TR and RB19 partial sequences included in our
alignments are listed in S1 Table. We prioritized the selection of the RB19 and TR isolates
included in the alignment, based on the availability of sequences for both genes, overlap with
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isolates included in the COII-ND1 alignment when possible, as well as representation from a
broad geographic range.
Two different approaches have been used to amplify the contiguous COII-ND1maxicircle
genes, which span a region of approximately 1,594 bp (CL Brener strain, GenBank
#DQ343645). The first approach results in separate partial sequences for each gene, yielding
short fragments of 417 bp and 369 bp for COII and ND1, respectively [42, 46]. The second
approach, and the one applied in this study, generates a COII-ND1 combined partial sequence
of approximately 1,272 bp in length [21, 35, 39]. The two shorter gene fragments obtained via
the first method are completely nested within this longer combined sequence. The goal of our
phylogenetic analyses was to maximize the number of unique T. cruzi sequences included,
while ensuring that isolates represented a wide geographic range, especially within the TcI
DTU. Therefore the alignment of our COII-ND1 sequences was not limited to published
sequences of similar length, but also included the shorter separate gene sequences obtained in
studies where the first approach was applied (S1 Table). Following alignment, all COII-ND1
sequences (n = 62) were trimmed and manually concatenated to a final length of 786 bp (369
+ 417), representing the two separate gene fragments.
Phylogenetic trees for the RB19, TR and COII-ND1 gene sequences were re-constructed in
MEGA6 via Neighbor-Joining (NJ) and Maximum Likelihood (ML) methods. In the NJ
approach, the evolutionary distances were computed using the maximum composite likelihood
method [47] with 2,000 bootstrap replicates. For the ML trees, the best fit model (as deter-
mined via the Model Test option in MEGA6) was run with 500 bootstrap replicates. The boot-
strap support of the resulting NJ and ML phylogenies were compared for each genetic marker,
and the best supported tree was selected. For trees displaying similar topology, both NJ and ML
bootstrap values were included at appropriate nodes. In all cases, the trees were outgroup
rooted with T. cruzi marinkellei.
The discovery of an apparent TcI/TcIV hybrid was further evaluated via the comparison of
pairwise-distances between this sample and representative samples of TcI and TcIV for each
genetic marker (i.e. T. cruzi sequences included in the reconstruction of the respective phyloge-
netic trees). The uncorrected p-distances were calculated in MEGA6 using pairwise deletion
and transitions/transversions as the substitution types. The program Dna-SP version 5.10 [48]
was used to calculate diversity indices for the TR, RB19 and COII-ND1 TcI sequences obtained
in this study. The TcIV sequences were not analyzed due to their limited number. Haplotype
diversity (Hd), nucleotide diversity (Pi), G+C content and the number of segregating sites (sin-
gleton + parsimony informative polymorphic sites) were calculated for all genes. The number
of synonymous and non-synonymous mutations, as well as the ratio of number of nonsynon-
ymous substitutions per site to synonymous substitutions per site (dN/dS), were calculated for
the TR and RB19 genes but were omitted from the COII-ND1 analysis due to the putative RNA
editing that occurs within the maxicircle gene [49].
Results
A total of 29 triatomine bugs were collected from the Vallecito study area, of which 24 (two
adults and 22 nymphs) were found within woodrat houses. The five remaining bugs were
adults obtained from either light traps or within a resident’s home. All identified bugs were
Triatoma protracta. The two PCR-based screening assays targeting different T. cruzi genomic
loci showed a high degree of concordance in the DNA extracted from all bugs. The 121/122
kinetoplast minicircle assay was marginally more sensitive, detecting 16 positive bugs, whereas
the TcZ1/TcZ2 nuclear assay only identified 15 of these same bugs as positive. Kinetoplast
T. cruziMolecular Diversity in California, USA
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DNA sequences obtained from the single discordant sample confirmed the presence of T. cruzi
DNA. Thus 55.2% of bugs at the Vallecito site were infected with T. cruzi.
At the Escondido study site, 53 bugs were collected, all of which were adult Tr. protracta
drawn to light traps. Thirteen bugs were positive for both T. cruzi PCR screening assays; how-
ever, positive amplification was detected for an additional six bugs using only the kDNA mini-
circle assay. Five of these discordant samples were successfully cloned and sequenced to
confirm the presence of T. cruzi DNA, yielding the conclusion that 18 bugs (34%) were T. cruzi
positive at the Escondido location.
There were 15 Tr. protracta bugs submitted from public health employees in southern Cali-
fornia, three of which were positive for parasite DNA on both screening assays (20%; there
were no discordant results for screening assays among this set of bugs). With the exception of
one specimen from San Diego, these bugs represented a range of locations within the Greater
Los Angeles Area: Agoura Hills, Altadena, Los Angeles, Northridge, Oak Hills, Santa Clarita,
Simi Valley, Tarzana, and Thousand Oaks (S1 Fig). Of the 11 bugs for which addresses were
provided, area visualization via GoogleEarth revealed that the homes primarily abutted natural
canyon areas designated as parks or were within housing tracts interspersed with parcels of
undeveloped land. A summary of the T. cruzi positive bugs is shown in Table 2. Together these
data confirm that wild populations of Tr. protracta at multiple sites in California are frequently
infected with T. cruzi.
We next aimed to investigate which T. cruzi subtype/DTUs were present using lineage-spe-
cific genotyping on a subset (n = 29) of the positive bugs, as described in Fig 1. Within this sub-
set, DTU determination was successful only for those samples that were positive for both of the
T. cruzi screening assays described above (n = 22). Samples that were parasite positive only for
Table 2. Trypanosoma cruzi results for Triatoma protracta specimens. Represented are screening results for all samples tested and discrete typing
units (I or IV) for a subset of specimens from each geographic region, based on phylogenetic assays.
Region = % (n/N)1 Sample ID2 RB193 TR3 COII-ND13
Vallecito = 55 (16/29) Vall3 I I I
Vall7 I I I
Vall8 I I I
Vall13 I I I
Vall14 I I I
LA Region = 20 (3/15) SoCal1 I I I
SoCal2 I I I
SoCal3 I I I
Escondido = 34 (18/53) Esc2 I I I
Esc19 IV IV IV
Esc264 IV IV I
Esc46 I I I
1Percent bugs positive for each geographic region as determined by highly sensitive nuclear and kinetoplast screening assays (# positive/# tested).
LA = Los Angeles.
2SoCal1 and SoCal2 were from Los Angeles and Santa Clarita, respectively. The exact location of SoCal3 was unknown. This bug was submitted from a
health agency via a wildlife rehabilitation center in Ventura County. An opossum was transferred to the center from an animal shelter in Los Angeles
County, and upon arrival, the bug was found in the bedding material within the opossum crate.
3Partial gene sequences were submitted to GenBank for RNA binding-protein-19 (RB19), trypanothione reductase (TR), and cytochrome oxidase/NADH
dehydrogenase subunit 1 (COII-ND1) under the respective accession numbers: KR108801-KR108812, KR108813-KR108827 and KR135412-KR135425.
4Esc26, which displayed incongruency between nuclear (TcIV) and maxicircle (TcI) genes, was categorized as TcI via the DTU assays described in Fig 1.
doi:10.1371/journal.pntd.0004291.t002
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the more sensitive 121/122 assay (n = 7) likely had insufficient DNA to amplify the lower copy
number DTU gene targets. We detected 13 and 7 TcI samples from the Vallecito and Southern
California locations, respectively. We found only two TcIV samples, both of which were from
the Escondido location. Thus, the T. cruzi TcI and TcIV DTUs are both endemic in California.
The T. cruzi DTUs that we identified are known to contain substantial genetic diversity [35,
50–53]. We therefore generated nucleotide sequence data to investigate our sample diversity at
the intra-DTU level and to enable comparison with strains from other studies. Sequences from
two nuclear genes (TR and RB19) consistently classified our Californian (CA) samples into TcI
(n = 10) and TcIV (n = 2) DTUs, confirming our previous genotyping results (Figs 2 and 3).
The TR gene demonstrated greater sequence diversity across CA samples than did the RB19
gene: thirteen vs. two unique haplotypes identified respectively. The RB19 gene sequences for
the 10 CA TcI samples were identical and indistinguishable from a single TcI sequence from
an opossum isolate [38] obtained from the US state of Georgia (Fig 2). Likewise, the TcIV
Fig 2. Phylogeny for 26 Trypanosoma cruzi 350 bp RNA-Binding Protein-19 (RB19) sequences. Neighbor-Joining tree constructed in MEGA6 with
evolutionary distances computed via MaximumComposite Likelihood. The numbers above the nodes represent bootstrap confidence levels for 2,000
replicates. Only values 50% are shown. The only TcI isolate not obtained in this study is represented by a square. Sequences obtained in this study are
indicated by a triangle (Esc = Escondido, SoCal = Southern California, Vall = Vallecito). All other isolates represent published GenBank sequences as listed
in S1 Table with their country origin indicated in parentheses. The scale bar indicates the number of nucleotide substitutions per site. Tree is outgroup rooted
with T. cruzi marinkellei (TcMark CONTIG 1404).
doi:10.1371/journal.pntd.0004291.g002
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RB19 sequences were identical for the two CA samples (Esc19 & Esc26), as well as for two
other US samples in GenBank (from a dog of unknown origin and a raccoon from Georgia). In
contrast, for the TR gene, 2 to 8 single nucleotide polymorphisms (SNPs) were detected among
both the TcI and TcIV-positive CA samples (Fig 3). The CA samples were distinguished from
two GenBank TcIV sequences from Guatemala and Brazil by 11 to 14 SNPs. Within the TcI
group, all the sequences from this study were closely related. The most closely related database
sequences were from the US and northern South America (Colombia and Venezuela). Three of
the southern CA sequences (Esc2, SoCal1 allele 1 and SoCal3) were identical to each other, as
well as to an isolate obtained from a bug collected in the state of Florida (GenBank
#AF358970) [35]. For the TR gene, the phylogenetic reconstruction between the NJ and ML
trees was very similar, and bootstrap values for both trees are presented at congruent nodes
(Fig 3). In contrast, the NJ and ML topology for the RB19 gene varied within major clades, and
only the NJ tree is represented (Fig 2).
For the maxicircle COII-ND1 genes, the NJ and ML tree topologies were very similar within
the TcI clade, but the NJ tree provided better support within the TcIV clade. We therefore pres-
ent the NJ tree with both NJ/ML bootstrap values indicated at congruent nodes (Figs 4 and 5).
Eleven of the twelve samples in this study were categorized as TcI based on the analysis of the
maxicircle COII-ND1 genes (Table 2 and Fig 4). Phylogenetic analysis of the concatenated
COII-ND1 sequences revealed that the CA TcI sequences obtained in this study were grouped
with strong bootstrap support (96%) in a subclade (Fig 5, subclade 1) with other North Ameri-
can isolates (US and Mexico), as well as several isolates from Central America (i.e. Guatemala
and Honduras). In addition, Colombian and Venezuelan isolates previously classified within
either “sylvatic” or “domestic” genetic populations [42] were also included in this subclade.
Thus, the composition of sequences within subclade 1 closely corresponded to that of the
group described elsewhere as TcI-Dom, which contains a high proportion of TcI strains associ-
ated with human infection across the Americas [46, 51, 53].
Esc19 was the only sample classified as having a TcIV maxicircle sequence, varying by only
2–3 SNPs from the southeastern US isolates (Fig 4). Interestingly, the Esc26 COII-ND1
sequence, which was defined as TcIV via the RB19 and TR nuclear gene sequences, as well as
the DTU assays, was classified as TcI and was identical to those sequences obtained for Esc2
and Esc46, both of which were typed as TcI by all other markers tested. These data are most
consistent with the Esc26 sample being the product of a genetic exchange event between TcI
and TcIV ancestors, leading to TcI mitochondrial introgression into a TcIV nuclear genomic
background.
The p-distances presented in Table 3 highlight the genetic exchange between TcI and TcIV
observed in sample Esc26. With respect to the RB19 and TRmarkers, Esc 26 was more closely
related to TcIV than TcI by an order of magnitude. In contrast, for COII-ND1, the reverse find-
ing was apparent. Table 4 provides values for the diversity indices calculated in Dna-SP. As
seen in the phylogenetic analyses, no diversity was observed within the TcI sequences for the
RB19 gene, whereas the TR and COII-ND1 genes are more genetically diverse.
Discussion
The overall T. cruzi prevalence of 55.2% (16/29) in the Vallecito triatomine population is the
highest reported for Tr. protracta. This infection level is comparable to that found in Triatoma
gerstaeckeri, a US triatomine species that was implicated in a 2006 case of acute Chagas disease
acquired in Texas [6]. Furthermore, if only the adult Tr. protracta Vallecito specimens collected
in this study are considered, the T. cruzi prevalence increases to 71.4% (5/7). In contrast, this
study’s prevalence of T. cruzi in adult Tr. protracta in Southern California (34% for Escondido
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Fig 3. Phylogeny for 35 Trypanosoma cruzi 1288 bp trypanothione reductase sequences. Depicted is the Neighbor-Joining (NJ) tree constructed in
MEGA6 with evolutionary distances computed via the MaximumComposite Likelihood method and the scale bar indicating the number of nucleotide
substitutions per site. The numbers above or below the nodes represent the bootstrap confidence levels for 2,000 NJ replicates (1st value) and 500 Maximum
Likelihood replicates (2nd value presented at nodes with congruent topologies) run under the Kimura 2-parameter model for those values 50%. Sequences
obtained in this study are indicated by the triangles (Esc = Escondido, SoCal = Southern California, Vall = Vallecito). All other isolates represent published
GenBank sequences as listed in S1 Table with their country of origin indicated in parentheses. Tree is outgroup rooted with T. cruzi marinkellei (GenBank
#AF359007).
doi:10.1371/journal.pntd.0004291.g003
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specifically; 27.9% across all Southern California samples) is consistent with previous infection
levels for this species, which have ranged from 20–36% in Southern California [25, 54]. The
only published case of locally acquired human Chagas disease in California occurred in Tuol-
umne County [55, 56], just south of Calaveras County where our Vallecito study site was
located. Our data show that Tr. protracta populations in both northern and southern California
have high frequencies of T. cruzi infection, indicating that the risk for transmission to people
and domestic animals is widespread in these regions.
In this research, we successfully amplified T. cruzi DNA of both mitochondrial (COII-ND1)
and single-copy nuclear genes (TR and RB19) directly from Tr. protracta DNA extracts. Direct
testing is commonly done for T. cruzi screening purposes using highly sensitive assays that tar-
get genes possessing thousands of copies (i.e. minicircle kinetoplast targets) or nuclear tandem
repeat regions. However, to our knowledge, previous research on the COII-ND1, TR and RB19
Fig 4. Phylogeny for 62 Trypanosoma cruzi concatenated 786 bp cytochrome oxidase II-NADH 1 (COII-ND1) sequences. The TcI clade is condensed
in this figure and contains the majority of the sequences obtained in this study (see Fig 5 for expanded version). Depicted is the Neighbor-Joining (NJ) tree
constructed in MEGA6 with evolutionary distances computed via the MaximumComposite Likelihood method and the scale bar indicating the number of
nucleotide substitutions per site. The numbers above or below the nodes represent the bootstrap confidence levels for 2,000 NJ replicates (1st value) and
500 Maximum Likelihood replicates run under the Tamura 3-parameter model (due to slightly incongruent topology, ML bootstrap values are only shown at
three nodes) for those values 50%. Only one sequence obtained in this study (Esc19 = Escondido 19) was grouped as TcIV based on mitochondrial gene
sequences. All other isolates represent published GenBank sequences as listed in S1 Table with their country of origin indicated in parentheses. Tree is
outgroup rooted with T. cruzi marinkellei (GenBank #AF359054).
doi:10.1371/journal.pntd.0004291.g004
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Fig 5. TcI subtree represented as TcI on Fig 4 showing four distinct subclades. This subtree includes 46
COII-ND1 concatenated sequences (786 bp). The scale bar indicates the number of nucleotide substitutions
per site for the NJ tree. The numbers above or below the nodes represent the bootstrap confidence levels for
2,000 NJ replicates (1st value) and 500 Maximum Likelihood replicates run under the Tamura 3-parameter
model. Only bootstrap values 50% are shown. Sequences obtained in this study are indicated by the
triangles (Esc = Escondido, SoCal = Southern California, Vall = Vallecito). Esc26 was grouped with TcI in this
analysis but was grouped with TcIV in all other analyses. All other isolates represent published GenBank
sequences as listed in S1 Table with their country of origin indicated in parentheses.
doi:10.1371/journal.pntd.0004291.g005
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genes have only used DNA extracted from pure T. cruzi cultures [21, 36, 40, 42]. Thus it is valu-
able to note that these assays are sensitive enough for analysis of triatomine bug extracts that
have tested positive for T. cruzi via the TcZ1/TcZ2 assay.
We found greater genetic diversity in Escondido, where both TcI and TcIV DTUs were
present as compared to Vallecito where only TcI was detected. Of particular interest is the
determination that one of the Escondido samples (Esc26) belonged to TcIV based on DTU and
nuclear phylogeny analyses, but that this same sample was grouped with TcI isolates based on
the mitochondrial maxicircle COII-ND1 sequence analysis. To our knowledge, this is the first
report of T. cruzi possessing TcIV nuclear genes and TcI mitochondrial genes. The reverse
incongruency, first reported by Machado and Ayala [35] and interpreted as evidence of rare
genetic exchange events, has been documented in multiple opossum TcI T. cruzi isolates in the
southeastern US [21].
In the only other molecular typing study performed on T. cruzi in California [25], samples
were obtained from Tr. protracta specimens collected from two southern sites, including the
same suburban property in Escondido from which our samples were collected. In this earlier
research, Hwang et al. [25] used the D71/D72 primer set employed in our DTU algorithm to
obtain partial sequences of the 24sα ribosomal RNA gene for two samples. Although the
authors did not identify these two samples as TcI, alignment of their two sequences
(GU594186 & GU594187) with sequences from three of our TcI Escondido samples
(KT879367-KT879369) differed by only 2–3 SNPs. It can therefore be inferred that the T. cruzi
samples obtained in the earlier research were also TcI.
With the exception of two samples, our T. cruzi sequences were all classified as TcI. By con-
trast, in the southeastern states, Roellig et al. [21] identified twice as many TcIV as TcI isolates.
However, this finding may simply reflect host sampling bias and culture success, as isolates
were cultured and examined from 21 raccoons versus only nine opossums. In the southeast,
raccoons are predominately infected with TcIV, whereas opossums have only been found to be
infected with TcI [1, 21]. In California and southwestern states, woodrats are the presumed pri-
mary reservoir of T. cruzi. Research in Texas found that southern plains woodrats (Neotoma
micropus) were hosts to both TcI and TcIV [9], and it is therefore not surprising that both
DTUs were present in our Escondido study site where woodrat nests were extremely abundant.
Our study represents the most northerly site of T. cruzi genotyping to date and therefore
extends the known range of TcI. The fact that we did not detect TcIV in our northern site may
be due to our smaller sample size in this region or reflect a true absence of this DTU. A geo-
graphical distribution for TcIV that extends as far north as Calaveras County remains a possi-
bility; indeed skunks (Mephitis mephitis) and raccoons, known hosts of TcIV are present in
this region and would be interesting to target for future research.
Table 3. Mean uncorrected pairwise-distances for Esc26. Each p-distance represents the average pro-
portion of nonidentical nucleotide positions between Esc26 and the TcI and TcIV T. cruzi sequences used to
generate the RNA-binding protein-19 (RB19), trypanothione reductase (TR) and cytochrome oxidase
II-NADH 1 (COII-ND1) phylogenetic trees. The number of nucleotide positions (bp) for each gene is indicated,
as is the number of comparison sequences (n) evaluated within each category.
TcI TcIV
Genetic Marker (bp) p-distance (SD) n p-distance (SD) n
RB19 (350) 0.0198 (0.00174) 14 0.00143 (0.00286) 4
TR (1288) 0.0163 (0.00106) 22 0.00684 (0.00321) 4
COII-ND1 (792) 0.00592 (0.00489) 46 0.0769 (0.00192) 6
doi:10.1371/journal.pntd.0004291.t003
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Our phylogenetic analysis of the concatenated maxicircle genes indicated that the TcI hap-
lotypes from this study clustered within a subclade containing isolates from Venezuela, Colom-
bia, Central America (Guatemala and Honduras) and North America. Included in this
subclade were strains from Venezuela (strains 10462P2C3 and 11541) representing a domicili-
ated T. cruzi genetic population (VENdom/TcIdom) that has been associated with human infec-
tions [42, 46]. In a phylogenetic analysis based on nine concatenated maxicircle sequences, the
TcIdom strains were similarly nested among North and Central American TcI strains [46]. The
authors suggested that these results provided evidence for initial human contact with TcI
occurring in North-Central America, with subsequent southerly movement of TcIdom as early
colonizing Amerindians migrated south. However this previous analysis included T. cruzi
sequences from only four US isolates, all of which originated in the southeastern US. Thus the
placement of all our CA TcI samples in the same COII-ND1 subclade as TcIdom strains provides
further phylogenetic support for the close relationship of US TcI isolates to TcIdom and so
strengthens the conclusions proposed by these authors.
The gene sequences examined in this study only represent a fraction of the T. cruzimaxicir-
cle and nuclear DNA. Genome scale analysis would enable a better understanding of the
genetic relationships between strains found in the US and Latin America. Genetic analyses of
US T. cruzi sequences obtained in this study and a limited number of US isolates included in
other studies [42, 46] have revealed that US TcI haplotypes are similar, or even identical, to
partial gene sequences of several Latin American T. cruzi strains associated with human illness.
Therefore, although some researchers have questioned whether local T. cruzi strains are as
infective or virulent as strains found in Latin America [5, 57, 58], our data suggest there is little
genetic basis for considering US strains to have any particular unique characteristics that
would distinguish them from Central American or most domestic South American TcI strains.
In fact, US T. cruzi strains have been demonstrated to infect and cause clinical symptoms and
pathology in dogs [59–61], non-human primates [62, 63] and humans [56, 64], including a
Texas prisoner who contracted acute Chagas disease as a result of an unethical experimental
study conducted in 1940 prior to the identification of the first case of autochthonous human
Chagas disease in the US [65]. Nevertheless, there are few documented cases of locally acquired
human Chagas disease in the US, and it has been proposed that the apparent rarity is most
Table 4. Comparative diversity indices for Trypanosoma cruzi TcI sequences obtained from Triatoma protracta specimens collected in California,
USA1. The data is represented for the overall combined (Total) populations, as well as at the regional population level (North = Vallecito; South = Escondido
and Los Angeles area).
Gene Pop bp No. H Hd Pi G+C S nSyn mut Syn mut dN/dS
RB19 Total 368 1 (20) 0.000 0.00000 0.568 0 0 0 n/c
North 368 1 (10) 0.000 0.00000 0.568 0 0 0 n/c
South 368 1 (10) 0.000 0.00000 0.568 0 0 0 n/c
TR Total 1288 10 (24) 0.913 0.00231 0.525 17 13 4 1.0150
North 1288 5 (10) 0.889 0.00304 0.526 11 9 2 1.4032
South 1288 8 (14) 0.884 0.00770 0.525 8 6 2 0.9379
COII-ND1 Total 1225 11 (24) 0.935 0.00287 0.262 18 nd nd nd
North 1225 5 (10) 0.867 0.00214 0.262 10 nd nd nd
South 1225 6 (14) 0.868 0.00227 0.261 8 nd nd nd
1Table abbreviations: Pop = population region, bp = Base pair alignment length, No. H = number of unique haplotypes (total number of haplotypes
analyzed), Hd = haplotype diversity, Pi = nucleotide diversity, G+C = Total G+C content, S = number of segregating sites (singleton + parsimony
informative sites), nSyn mut = Number of non-synonymous mutations, Syn mut = Number of synonymous mutations, n/c = not calculable, n/d = not done
due to putative RNA editing of this maxicircle gene.
doi:10.1371/journal.pntd.0004291.t004
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likely due to the infrequency of triatomine colonization within US homes [1, 5, 66] and reduced
vector-transmission efficiency [1].
In some regions of Latin America, rural houses are constructed of materials (i.e. adobe brick
walls, thatch roofs) that facilitate the invasion and exploitation of breeding niches by triato-
mines [67, 68]. In contrast, US standard housing construction likely hinders triatomines from
establishing breeding colonies once adult bugs have entered homes [69]. However, it is con-
ceivable that outdoor pet enclosures or substandard housing might be subject to colonization
events if these structures were adjacent to natural areas with triatomine bug populations, espe-
cially if preferred breeding sites and sylvatic hosts had recently diminished. For example, adult
Tr. protracta have been reported to disperse into human residences following the destruction
of woodrat nests associated with construction activities [70]. Likewise, following environmental
changes in Louisiana spurred by the wake of hurricane Katrina, infestations of Tr. sanguisuga
in human dwellings may have been related to the triatomines’ search for new bloodmeal
sources [7].
Emphasis has been placed on T. cruzi vector-human transmission being less efficient in the
US due to the delayed defecation habits of some US triatomine bug species [1]. Yet experimental
studies conducted on immobilized mice have demonstrated that two southwestern US species of
triatomines, Tr. protracta and Triatoma rubida, may defecate upon repletion, that is, immedi-
ately after terminating a blood meal and disengaging from the host [54]. The relevance of these
experimental studies with respect to the natural feeding behavior of Tr. protracta in human
homes is not clear; however, given that 75% (6/8) of the observed Tr. protracta defecations
occurred either before or upon repletion, the risk of T. cruzi vector transmission by this triato-
mine species cannot be disregarded. Furthermore, although the close ecological associations of
some US triatomine species (i.e. Tr. protracta and woodrats) suggest host feeding preferences,
bloodmeal analysis has indicated that vectors are not truly host-specific. In studies performed in
California and Arizona, human blood in addition to other host species (e.g. chickens, pigs and
wildlife), were identified from three triatomine species: Tr. protracta, Triatoma recurva and Tr.
rubida [17, 71]. Thus, the risk of vectorial T. cruzi transmission from Tr. protracta and other US
triatomine species is likely to be greater than has been previously assumed.
In fact, recent T. cruzi screening of blood donors identified 16 asymptomatic cases of T.
cruzi infection most likely acquired from local vector transmission in the US [16]. Data extrap-
olated from this four-year screening study led the authors to conclude that vectorial transmis-
sion is not common within this country. However, one must consider the derivation of these
data, which is potentially subject to large sampling bias and thus may not represent the general
population. Specifically, T. cruzi screening was performed on asymptomatic blood donors who
presumably felt healthy at the time of blood donation. In contrast, it is probable that people
who feel unwell (some of whom may have chronic Chagas disease) do not choose to donate
blood. If these people do not seek health care, or if their physicians are unaware of the local risk
of Chagas infection, then the disease would go undiagnosed. Currently, Chagas disease is a
reportable disease in four states [72], with Texas just having recently listed Chagas as reportable
in late 2012 [73]. As these states and others begin to more closely track the incidence of human
T. cruzi infections, the true risk of vectorial transmission should become more apparent.
Conclusion
Our research is one of only two molecular studies on T. cruzi in California and the first to
investigate this parasite’s genetic diversity in the northern portion of the state. While this
study’s prevalence of T. cruzi in Tr. protracta populations in southern California (~30%) was
similar to earlier findings, an even higher prevalence was detected in our northern California
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study region. The genetic markers employed in this study allowed us to demonstrate the close
similarities between T. cruzi strains in California and those present in other US states, as well
as some Latin American countries. Thus, vectors across California present a clear transmission
risk to humans and dogs. Additionally, experimental studies have already proven that Tr. pro-
tracta can sustain a Honduran T. cruzi isolate [29], and Triatoma infestans and Rhodnius pro-
lixus, two vectors from Latin America, have been shown capable of harboring US T. cruzi
isolates [4]. Although the divergence and migration of T. cruzi strains occurred over a period
of millions of years [50, 53, 74], in this new era of global connectivity, vectors and the patho-
gens they carry may unknowingly be transported between countries [75, 76]. Therefore if tria-
tomine vectors efficient in T. cruzi transmission, and perhaps more readily able to colonize
human homes, were to be unwittingly introduced to the US, potential mixing of T. cruzi strains
could occur within and among vector species.
Despite the fact that T. cruzi has been known to exist in the US for at least 80 years, only
four states consider Chagas disease to be reportable. In late 2012, Texas became the fourth state
to declare Chagas a reportable disease, a decision preceded by a series of in-state studies and
clinical case reports on the disease in both canines and humans. Consistent with Texas, our
research implies that some areas of California may have a similar risk for T. cruzi transmission
and suggests that California physicians and veterinary practitioners should consider Chagas
disease as a potential cause of cardiac illness in regions where Tr. protracta populations are
evident.
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